EUTECNIQAtlas

Every page of EUTECNIQ on one mapArrow keys move through results · Enter opens · Esc closes

Supplements A–Z Amino acid and protein Sources: 7

L-arginine

Also called: arginine

L-arginine is an amino acid found in many protein-containing foods, especially animal products and nuts; typical dietary intake is 4–5 g/day. The body also makes arginine, mainly in the kidneys, from citrulline.

Category
Amino acid and protein
Forms
L-arginine; Health Canada also lists L-arginine monohydrochloride, L-arginine alpha-ketoglutarate, L-arginine ketoisocaproic acid and DL-arginine as source ingredients (oral, synthetic)
Strongest evidence
B Some positive trials
Reviewed
2026-10-30

Class 1 Well studied in people. A 2022 meta-analysis (Advances in Nutrition) included 22 RCTs of oral L-arginine versus placebo in adults, for blood pressure; infusion and acute studies were excluded. [4]

Fact-checked 2026-10-30 · How this guide is made

Education, not medical advice. These statements have not been evaluated by the Food and Drug Administration. This information is not intended to diagnose, treat, cure or prevent any disease, or to replace any medication or medical advice. EUTECNIQ sells no supplements today, and this page links to no product. Supplements can interact with medicines; ask a doctor or pharmacist before use, especially in pregnancy, while breastfeeding, before surgery or for a child.

Evidence

What research has studied

Grades describe the human evidence in the cited sources, not a recommendation. A means consistent randomized trials; X means good trials found no effect.

4 topics studied2 body areas · strongest grade B

A consistent trialsB some positive trialsC limited human evidenceD lab or animal onlyX no effect in good trials

From the table below Each topic in the table is placed on the part of the body it names, colored by its strongest grade. Tap an area, or open a line in the list, to see its topics. The map shows what was studied, not what L-arginine does: a C or X area is not evidence of benefit. All 1,071 findings on one body map.
Topics studied for L-arginine, evidence grade and finding
Topic studiedGradeWhat the evidence shows
Blood pressure in adultsBA 2022 meta-analysis of 22 RCTs (30 effect sizes) of oral L-arginine found lower systolic (−6.40 mmHg) and diastolic (−2.64 mmHg) pressure than placebo; no significant change was seen at doses above 9 g/day. [4]
24-hour ambulatory blood pressureBA 2026 meta-analysis of 5 RCTs (202 participants) reported lower 24-hour systolic (−4.23 mmHg) and diastolic (−3.04 mmHg) pressure with oral L-arginine; the authors note the number of included studies was limited. [5]
Vascular stiffness and heart function after acute myocardial infarctionXIn the VINTAGE MI trial (153 patients, 6 months), L-arginine added to standard care did not improve vascular stiffness or ejection fraction; 6 patients (8.6%) on L-arginine died versus none on placebo. [6]
Athletic performanceCODS calls the evidence limited and conflicting: 2–20 g/day appears to have little to no effect on aerobic or anaerobic performance, and a review of 54 mostly small studies found little or no enhancement. [1]

Main constituents: L-arginine, which can be converted to nitric oxide (a blood-vessel dilator) and is a precursor for creatine [1]

Amounts

Amounts studied and limits

Amounts used in research, not dosing advice. Products differ in form and strength; a clinician can advise on an individual dose.

  • Blood-pressure trials gave oral L-arginine for at least 4 days; the dose-response analysis detected an effect on systolic pressure at 4 g/day or more (2022 meta-analysis). [4]
  • VINTAGE MI: goal dose of 3 g three times a day for 6 months after a first ST-segment elevation myocardial infarction. [6]
  • Exercise studies described by ODS used 2–20 g/day; most lasted 4–8 weeks. [1]

No official upper intake level has been set.

Safety

Safety and side effects

  • Liver (NIH LiverTox)
    Nothing found

    No published information found in the sources checked.

    Details and sources
  • Pregnancy and breastfeeding
    Health Canada's L-arginine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding.

    1 statement in the profile.

    Details and sources
  • Interactions with medicines
    2 listed

    Blood pressure medicines (antihypertensives); Medicines for cardiovascular disease or erectile dysfunction, and blood thinners

    Details and sources
  • Cancer evaluations (IARC, NTP)
    None found

    No IARC or NTP evaluation was found in the lists checked.

    Details and sources
  • FDA new dietary ingredient notifications
    6 on FDA's list

    FDA does not approve dietary supplements. Each entry is one party's filing.

    Details and sources
  • Dose in official monographs
    Stated

    Health Canada NNHPD L-arginine monograph (July 25, 2025), adults 18 years and older: 0.21–21 g/day for protein synthesis, or 6–21 g/day for exercise …

    Details and sources
  • After a heart attack: in VINTAGE MI, deaths were higher with L-arginine (6 vs 0, P = .01), the safety monitoring committee closed enrollment, and the authors concluded L-arginine should not be recommended following acute myocardial infarction. [6]
  • MSK warns that arginine may increase risk of mortality in people who have had an acute myocardial infarction, and that long-term use may worsen peripheral artery disease. [2]
  • Health Canada's monograph states, for products providing more than 9 g/day: "Do not use if you have had a heart attack/myocardial infarction." [3]
  • ODS: up to 9 g/day for several days or weeks appears safe and well tolerated; at 9–30 g/day the most common reactions are gastrointestinal (such as diarrhea and nausea) and slightly lower blood pressure. The safety of high-dose use for more than 3 months is not known. [1]
  • MSK lists abdominal pain, bloating, nausea and diarrhea as adverse reactions, and notes that limited studies suggest arginine may increase breast tumor growth; more research is needed. [2]
  • Health Canada requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [3]
Interactions

Interactions

L-arginine
From the table below 2 interactions the sources name. Tap one to read what happens. A line means a documented or possible interaction, not its size.
Known interactions of L-arginine
WithWhat happens
Blood pressure medicines (antihypertensives)MSK states arginine could temporarily lower blood pressure in patients with diabetes and may have additive hypotensive effects. [2]
Medicines for cardiovascular disease or erectile dysfunction, and blood thinnersHealth Canada requires a caution (above 0.42 g/day) to ask a health care practitioner before use if taking these medicines. [3]

Tell a pharmacist or doctor about every supplement you take. All documented interactions in this hub.

Quality

Identity, quality and standardization

  • MSK notes that some protein powders or products claiming to improve sports performance may contain arginine. [2]
Regulation

Regulatory status

  • US: under DSHEA, FDA does not have the authority to approve dietary supplements before they are marketed; firms are responsible for ensuring their products are not adulterated or misbranded. [7]
  • Canada: Health Canada's L-arginine monograph (oral) includes the use "May help support a modest improvement in exercise capacity in individuals with stable cardiovascular diseases (CVD)." [3]
Profile

Safety, quality and supply profile

Fourteen questions a careful buyer, formulator or clinician would ask, each answered only from a cited source (checked 2026-10-29). If our sources do not answer a question, we say so.

Compounds responsible

Compounds the sources name as the main or characteristic actives.

  • L-arginine (proper name (S)-2-Amino-5-[(aminoiminomethyl) amino] pentanoic acid); synthetic preparation Amino acid [P5]

US status

What FDA's published records show. FDA does not approve dietary supplements.

  • FDA's published NDI notification list has 6 entries naming L-arginine as part of a salt, complex or mixture (for example L-arginine alpha ketoglutarate (2:1) and arginine silicate inositol complex); none names L-arginine alone (earliest NDI 230 submitted 2003-05-05; most recent NDI 786 submitted 2013-01-10). Each entry is one party's notification; the list gives the date of FDA's response letter but not what it said. [P1]

Cancer evaluations (IARC and NTP)

Evaluations name the exact material tested, which may differ from a supplement.

  • No IARC or NTP carcinogenicity evaluation of L-arginine was found (IARC Monographs list of classifications and NTP technical reports checked 2026-10-29). [P2]
  • The NTP Technical Reports index (TR-000 to TR-606) lists no study of arginine (checked 2026-10-29). [P3]

Liver (NIH LiverTox)

  • No published information found in the sources checked.

Interactions with medicines

  • Blood pressure medicines (antihypertensives): MSK states arginine could temporarily lower blood pressure in patients with diabetes and may have additive hypotensive effects. [P6]
  • Medicines for cardiovascular disease or erectile dysfunction, and blood thinners: Health Canada requires a caution (above 0.42 g/day) to ask a health care practitioner before use if taking these medicines. [P5]

Alcohol

  • No published information found in the sources checked.

Interactions with other herbs and supplements

  • No published information found in the sources checked.

Adulteration and substitution

  • No published information found in the sources checked.

What a certificate of analysis should cover

Tests a quality specification for this material would include, with the reason for each.

  • Identity: at least one appropriate test or examination to verify the identity of each component that is a dietary ingredient (21 CFR 111.75(a)(1)(i)) — General Part 111 requirement for every dietary ingredient; a firm may petition FDA for an exemption under 111.75(a)(1)(ii). [P4]

Supply and conservation

  • Health Canada's monograph lists the preparation of L-arginine as synthetic. [P5]

Absorption in people

  • ODS states citrulline may raise blood arginine levels more efficiently than arginine itself, because more citrulline is absorbed from the gut. [P7]

Formulations studied to change absorption

Human data only.

  • No published information found in the sources checked.

Dose in official monographs

As the monograph states it, for its jurisdiction; not personal advice.

  • Health Canada NNHPD L-arginine monograph (July 25, 2025), adults 18 years and older: 0.21–21 g/day for protein synthesis, or 6–21 g/day for exercise capacity in stable cardiovascular disease, not exceeding 8 g per single dose; duration statements apply at 3 g/day or more. [P5]

Pregnancy and breastfeeding

  • Health Canada's L-arginine monograph requires the caution to ask a health care practitioner before use if pregnant or breastfeeding. [P5]

Sources for this profile

  1. FDA. Submitted 75-Day Premarket Notifications for New Dietary Ingredients (list dated July 9, 2026), 2026-07-09. fda.gov
  2. IARC Monographs. List of Classifications: agents classified by the IARC Monographs, Volumes 1–142 (last updated 2026-07-23), 2026-07-23. monographs.iarc.who.int
  3. National Toxicology Program (NIEHS). Technical Reports index (TR-000 to TR-606, checked 2026-10-29), 2026-10-29. ntp.niehs.nih.gov
  4. eCFR. 21 CFR 111.75, What must you do to determine whether specifications are met? (up to date as of 10/23/2026), 2026-10-23. ecfr.gov
  5. Health Canada, NNHPD. Monograph: L-Arginine (monograph date July 25, 2025 as printed), 2025-07-25. webprod.hc-sc.gc.ca
  6. Memorial Sloan Kettering Cancer Center. About Herbs: Arginine (Last Updated February 10, 2022), 2022-02-10. mskcc.org
  7. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
Sources

Sources

  1. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Fact Sheet for Health Professionals (no printed update date; page last modified 2026-10-25 per page metadata), 2026-10-25. ods.od.nih.gov
  2. Memorial Sloan Kettering Cancer Center. About Herbs: Arginine (Last Updated February 10, 2022), 2022-02-10. mskcc.org
  3. Health Canada, NNHPD. Monograph: L-Arginine (monograph date July 25, 2025 as printed), 2025-07-25. webprod.hc-sc.gc.ca
  4. Shiraseb F, et al. Effect of l-arginine supplementation on blood pressure in adults: a systematic review and dose-response meta-analysis of randomized clinical trials. Adv Nutr 2022;13(4):1226-1242 (PMID 34967840), 2022-08-01. pubmed.ncbi.nlm.nih.gov
  5. Shi Y, et al. Reassessment of the effect of oral l-arginine on blood pressure: a systematic review and meta-analysis based on ambulatory blood pressure monitoring. Nitric Oxide 2026;164:60-68 (PMID 42520885), 2026-10. pubmed.ncbi.nlm.nih.gov
  6. Schulman SP, et al. L-arginine therapy in acute myocardial infarction: the VINTAGE MI randomized clinical trial. JAMA 2006;295(1):58-64 (PMID 16391217), 2006-01-04. pubmed.ncbi.nlm.nih.gov
  7. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements (content current as of 08/27/2026), 2026-08-27. fda.gov
A
Consistent results from several randomized trials or a systematic review of them
B
Some positive randomized trials, but small, short, few or inconsistent
C
Limited human evidence: single small trials, observational data or mixed results
D
Laboratory or animal evidence only; not shown in people
X
Well-designed human trials found no meaningful effect

More in amino acid and protein: 5-HTP (5-hydroxytryptophan) · Beta-alanine · BPC-157 · Branched-chain amino acids (BCAAs) · Carnosine (L-carnosine) · Collagen peptides · Creatine · Glutathione · All entries A–Z · How to judge a supplement

Health information notice

These statements have not been evaluated by the Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure or prevent any disease. The information is for general education only. It is not medical advice and does not replace advice, diagnosis or treatment from a qualified health professional, or any medication a clinician has prescribed.

Do not start, stop or change any medicine, supplement or herbal product because of something you read here. Talk to your doctor or pharmacist first, especially if you are pregnant or breastfeeding, have a medical condition, take any medicines, are preparing for surgery, or are caring for a child. Research findings, traditional uses and safety data are reported as their sources state them; they are not recommendations or claims about any product. If you think you may have a medical emergency, call your doctor or 911 at once.

EUTECNIQ Sciences sells no supplements or health products today and receives nothing from any product or ingredient mentioned on this site; any commercial interest it later has in an ingredient will be stated on that ingredient’s page.

Ready to check what you take?

Free tools built on published reference values, each with its sources and its limits. Your lists stay in your browser.